Paper Details

  1. Home
  2. Paper Details

Targeted Strategy in Lipid-Lowering Therapy.

Author: DayarEzgi, PechanovaOlga

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review discusses the most effective lipid-lowering drugs, including statins, ezetimibe, and PCSK9 inhibitors, and their mechanisms of action. While these drugs are beneficial, limitations like side effects and administration challenges exist. Targeted therapy, utilizing nanoparticle carriers, emulsions, or vaccination, is explored as a potential solution to enhance drug efficacy and minimize drawbacks.
Paper Details　
Original Abstract of the Article :
Dyslipidemia is characterized by a diminished lipid profile, including increased level of total cholesterol and low-density lipoprotein cholesterol (LDL-c) and reduced level of high-density lipoprotein cholesterol (HDL-c). Lipid-lowering agents represent an efficient tool for the prevention or reduc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138651/

データ提供：米国国立医学図書館（NLM）

Targeted Lipid-Lowering Therapy: A Precision Approach to Cardiovascular Health

Dyslipidemia, a condition characterized by abnormal lipid levels, is a major risk factor for cardiovascular disease. This research provides a comprehensive overview of lipid-lowering therapy, exploring the latest advancements in targeted drug delivery and the use of innovative therapies to effectively manage dyslipidemia.

Tailoring Treatment to Individual Needs: The Promise of Targeted Therapy

The authors highlight the importance of individualized treatment approaches and emphasize the potential of targeted therapy to address the limitations of traditional lipid-lowering medications. Targeted therapy involves delivering medications directly to the site of action, potentially enhancing efficacy while minimizing side effects.

The Future of Lipid-Lowering Therapy: A Focus on Precision

This research underscores the importance of ongoing research and innovation in the field of lipid-lowering therapy. The development of targeted therapy, nanoparticle carriers, and other innovative approaches promises to improve the effectiveness and safety of treatment, leading to better outcomes for patients with dyslipidemia.

Dr. Camel's Conclusion

Just as a camel adapts to the unique challenges of a desert environment, lipid-lowering therapy is increasingly focused on tailoring treatment to individual needs. The development of targeted therapy represents a promising new frontier in the fight against cardiovascular disease.

Date :
  1. Date Completed n.d.
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

35625827

DOI: Digital Object Identifier

PMC9138651

Related Literature

Article Analysis
・Side Effects of ezetimibe
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.